(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 27.33%3.15B | 17.54%1.29B | 19.51%2.47B | -6.91%1.1B | -17.93%2.07B | 17.26%1.18B | 12.18%2.52B | -7.70%1B | -3.72%2.25B | -6.87%1.09B |
Operating income | 27.33%3.15B | 17.54%1.29B | 19.51%2.47B | -6.91%1.1B | -17.93%2.07B | 17.26%1.18B | 12.18%2.52B | -7.70%1B | -3.72%2.25B | -6.87%1.09B |
Operating expenses | -38.92%-2.93B | -37.17%-1.26B | -30.36%-2.11B | -12.95%-919M | 19.77%-1.62B | -0.10%-813.66M | -2.47%-2.02B | 17.68%-812.84M | 5.87%-1.97B | -1.95%-987.42M |
Gross profit | -40.00%217.7M | -84.75%26.9M | -19.45%362.85M | -51.41%176.37M | -10.53%450.47M | 90.48%362.96M | 80.68%503.49M | 91.07%190.55M | 14.72%278.67M | -49.82%99.73M |
Selling expenses | -62.42%-8.09M | -87.84%-4.15M | 30.21%-4.98M | 38.56%-2.21M | 42.65%-7.14M | 89.97%-3.6M | 82.14%-12.45M | -8.35%-35.87M | -11.84%-69.73M | 10.95%-33.11M |
Administrative expenses | -54.00%-174.55M | -27.43%-64.76M | -2.92%-113.35M | 25.17%-50.82M | 39.02%-110.13M | -3.03%-67.91M | -40.57%-180.61M | -12.53%-65.92M | -6.21%-128.48M | -17.11%-58.58M |
Research and development expenses | -53.93%-102.93M | -91.79%-47.62M | -22.92%-66.87M | 11.35%-24.83M | 18.54%-54.4M | 8.80%-28.01M | -32.34%-66.78M | -33.38%-30.71M | -15.52%-50.46M | -25.60%-23.02M |
Profit from asset sales | 43.62%992.22K | --992.22K | 17.68%690.86K | ---- | 101.15%587.08K | -99.54%42.07K | -35,116.47%-51.23M | --9.17M | 163.44%146.3K | ---- |
Revaluation surplus | 293.95%39.69K | 152.83%4.33K | 40.89%-20.46K | 76.94%-8.2K | 77.72%-34.62K | 73.63%-35.54K | -2,833.88%-155.34K | -442.16%-134.78K | 94.85%-5.29K | -81.68%39.39K |
-Changes in the fair value of other assets | 293.95%39.69K | 152.83%4.33K | 40.89%-20.46K | 76.94%-8.2K | 77.72%-34.62K | 73.63%-35.54K | -2,833.88%-155.34K | -442.16%-134.78K | 94.85%-5.29K | -81.68%39.39K |
Impairment and provision | -3,981.42%-90.78M | -815.81%-15.13M | 87.27%-2.22M | 155.71%2.11M | -63.68%-17.47M | -323.97%-3.79M | -76.62%-10.68M | 34.92%-895.03K | 64.58%-6.04M | -97.68%-1.38M |
-Other impairment is provision | -3,981.42%-90.78M | -815.81%-15.13M | 87.27%-2.22M | 155.71%2.11M | -63.68%-17.47M | -323.97%-3.79M | -76.62%-10.68M | 34.92%-895.03K | 64.58%-6.04M | -97.68%-1.38M |
Special items of operating profit | 137.36%44.76M | 16.32%13.68M | 22.49%18.86M | -19.82%11.76M | -88.55%15.4M | -1.03%14.67M | -23.00%134.5M | -85.85%14.82M | -4.77%174.66M | -39.77%104.74M |
Operating profit | -179.41%-136.89M | -201.40%-102.66M | -32.69%172.39M | -61.44%101.24M | -15.38%256.12M | 249.59%262.52M | 61.99%302.68M | -9.52%75.09M | 8.46%186.85M | -67.93%83M |
Financing cost | -22.58%-88.32M | -7.81%-40.82M | -3.76%-72.05M | -1.50%-37.86M | 50.76%-69.44M | 24.11%-37.3M | -32.18%-141.01M | 6.17%-49.16M | -22.44%-106.68M | -60.84%-52.39M |
Special items of earning before tax | -183.91%-378K | -616.71%-562.78K | -55.90%450.48K | 94.12%-78.52K | -89.42%1.02M | -114.10%-1.34M | 339.98%9.65M | 9,978.00%9.48M | -323.23%-4.02M | -1,116.32%-95.95K |
Earning before tax | -323.82%-225.59M | -327.57%-144.04M | -46.31%100.79M | -71.73%63.29M | 9.56%187.71M | 532.16%223.89M | 124.97%171.32M | 16.06%35.42M | -12.42%76.16M | -86.51%30.51M |
Tax | 53.57%-5.37M | -58.79%-3.49M | 50.34%-11.56M | 75.01%-2.2M | -176.83%-23.28M | -346.91%-8.78M | 1,563.50%30.29M | -278.63%-1.97M | -1,107.03%-2.07M | 121.54%1.1M |
After-tax profit from continuing operations | -358.83%-230.96M | -341.45%-147.52M | -45.73%89.23M | -71.60%61.1M | -14.34%164.43M | 543.04%215.1M | 159.10%191.96M | 5.81%33.45M | 231.32%74.09M | -85.71%31.61M |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | --9.66M | ---- | ---- | ---- |
Earning after tax | -358.83%-230.96M | -341.45%-147.52M | -45.73%89.23M | -71.60%61.1M | -18.44%164.43M | 543.04%215.1M | 172.15%201.62M | 5.81%33.45M | -14.63%74.09M | -85.71%31.61M |
Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | 5.32%-18.04M | 40.09%-8.1M | -447.23%-19.06M | -170.65%-13.52M |
Profit attributable to shareholders | -358.83%-230.96M | -341.45%-147.52M | -45.73%89.23M | -71.60%61.1M | -25.14%164.43M | 417.67%215.1M | 135.84%219.66M | -7.94%41.55M | 14.57%93.14M | -77.66%45.14M |
Basic earnings per share | -358.82%-1.3099 | -341.47%-0.8367 | -59.01%0.5061 | -78.54%0.3465 | -25.14%1.2346 | 8,582.80%1.615 | 3,855.16%1.6493 | -7.92%0.0186 | 14.56%0.0417 | -77.56%0.0202 |
Diluted earnings per share | -358.82%-1.3099 | -341.47%-0.8367 | -59.01%0.5061 | -78.54%0.3465 | -25.14%1.2346 | 8,582.80%1.615 | 3,855.16%1.6493 | -7.92%0.0186 | 14.56%0.0417 | -77.56%0.0202 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data